The 2023 Prohibited List: Summary of Changes
Looking for information on the 2024 Prohibited List? View the 2024 Prohibited List Summary of Changes
Information below on the 2023 Prohibited List which was released on 1 January 2023:
- The List designates the substances and methods that are prohibited in sport
- The 2023 Prohibited List will come into effect on 1 January 2023
- Tramadol will be prohibited in-competition from 1 January 2024
The World Anti-Doping Agency (WADA) has recently released the 2023 List of Prohibited Substances and Methods (the List). Broken down into several categories, the List identifies which substances and methods are prohibited at all times, in-competition only, and within specific sports.
Following an extensive consultation period by WADA, the 2023 Prohibited List was published on 29 September 2022. This gives athletes and their support personnel sufficient time to make themselves aware of the changes, review any medications they use, and apply for a Therapeutic Use Exemption (TUE) if required before the updated List comes into effect on 1 January 2023.
While no major changes have been made, further examples of prohibited substances have been added to various categories of the 2023 Prohibited List. Please note, these are not new substances being added to the List for the first time but additional examples of substances that are already prohibited.
- Androst-4-ene-3,11,17-trione (11-ketoandrostenedione, adrenosterone)
- 17ɑ-methylepithiostanol (epistane)
- 1,3-dimethylamylamine (1,3 DMAA)
- 1,4-dimethylamylamine (1,4-DMAA)
For further information on the full list of modifications please consult the 2023 List of Prohibited Substances and Methods and the 2023 Summary of Major Modifications and Explanatory Notes.
WADA has also published the 2023 Monitoring Program which lists substances (not on the Prohibited List) that are currently being monitored for potential misuse.
UKAD will be making resources available to National Governing Bodies to assist in reminding their athletes of what they need to do ahead of 1 January 2023.
Separately, WADA’s Executive Committee approved the List Expert Advisory Group’s recommendation to prohibit the narcotic tramadol in-competition, effective as of 1 January 2024.
This delay in implementation is to enable athletes and athlete support personnel to prepare for the change, WADA-Accredited Laboratories to update their procedures, and sports authorities to develop educational tools.
UKAD will be releasing further information and resources to athletes, athlete support personnel and National Governing Bodies in autumn 2023.